Abstract:Objective To quantify the changes in blood glucose, blood lipids, blood pressure, and the intima-media thickness (IMT) of large arteries in patients with new-onset type 2 diabetes mellitus who received either intensive multifactorial treatment or conventional treatment. Methods Two-hundred and ten patients with new-onset type 2 diabetes mellitus were randomly assigned to two groups: an intensive treatment group ( n =110) and a conventional treatment group ( n =100). Fasting blood glucose (FBG), glycosylated hemoglobin A1c (HbA1c), blood pressure, blood lipids [total cholesterol (TC), triglyceride (TG), low-density lipoprotein C (LDL-C), and high-density lipoprotein C (HDL-C)], and IMTs of large arteries (carotid, iliac, and femoral arteries) were determined before and at one and two years after starting treatment. The patients in the conventional treatment group received routine diabetes management in our outpatient department. Targets were established for patients in the intensive treatment group. Their blood glucose, blood lipids, and blood pressure levels were regularly monitored and therapeutic regimens were adjusted for those whose measurements did not meet the target values until all the parameters met the established targets. Within-group and between-group differences were evaluated. Results A significantly greater percentage of patients in the intensive treatment group had LDL-C levels that reached the target value one year after starting treatment than those in the conventional treatment group (52.04% vs. 33.33%, P <0.05). No significant differences were found between groups for FBG, HbA1c, blood pressure, TG, TC, or HDL-C. The percentages of patients with TG (51.02% vs. 34.48%), TC (52.04% vs. 33.33%), and LDL-C (61.22% vs. 43.67%) who met the respective target values in the intensive treatment group were all significantly higher than the corresponding percentages in the conventional treatment group two years after starting treatment ( P <0.05). There were no significant differences in the percentages of patients with FBG, HbA1c, and blood pressure values meeting the respective targets between the groups at the two-year follow-up. One year after starting treatment, the LDL-C level, diastolic blood pressure (DBP), and the IMTs of the femoral and iliac arteries of the intensive treatment group were significantly lower compared to those of the conventional treatment group ( P <0.05), although there was no significant difference in other metabolic parameters. Two years after starting treatment, the TC, LDL-C, blood pressure [systolic blood pressure (SBP) and DBP], and the IMTs of the carotid and femoral arteries of the intensive treatment group were significantly lower than those of the conventional treatment group ( P <0.05). No significant differences in other metabolic parameters existed between the two groups two years after starting treatment. Conclusions Early comprehensive and intensive treatment of type 2 diabetes mellitus can delay or even reverse the increase in IMT of large arteries. Lowering blood pressure and blood lipid regulation in patients with type 2 diabetes mellitus have great significance in decreasing the risk of diabetes-related macrovascular lesions.

[OP.2D.06] DIFFERENCES IN ENDOTHELIAL GLYCOCALYX IN RECENTLY DIAGNOSED AND UNTREATED MIDDLE-AGED HYPERTENSIVE PATIENTS REGARDING INCREASED CARDIOVASCULAR RISK

[PP.36.10] ENDOTHELIAL GLYCOCALYX DIMENSIONS ARE SIMILAR IN NORMOTENSIVES AND LOW RISK UNTREATED HYPERTENSIVE PATIENTS

[OP.8C.08] DIFFERENCES IN ENDOTHELIAL GLYCOCALYX DIMENSIONS IN HYPERTENSIVE PATIENTS WITH EXTREME HIGH DENSITY LIPOPROTEIN CHOLESTEROL (HDL-C) LEVELS

INCREASED HDL CHOLESTEROL LEVELS RELATE TO ENDOTHELIAL GLYCOCALYX INTEGRITY IN OLDER TREATED PATIENTS WITH ESSENTIAL HYPERTENSION

P1680High density lipoprotein cholesterol (HDL-C) levels and endothelial glycocalyx integrity in treated hypertensive patients

Impaired Endothelium-dependent Vasodilatation in Different Level of Risk in Essential Hypertension

Effect of Intensive Multifactorial Treatment on the Intima-Media Thickness of Large Arteries in Patients with New-Onset Type 2 Diabetes Mellitus

Effect of Smoking on Common Carotid Artery Wall Elasticity Evaluated by Echo Tracking Technique

HDL cholesterol levels and endothelial glycocalyx integrity in treated hypertensive patients

[PP.09.09] IMPROVEMENT OF ENDOTHELIAL GLYCOCALYX AND AORTIC STIFFNESS AFTER ONE YEAR OF SUCCESSFUL TREATMENT IN UNTREATED PATIENTS WITH ESSENTIAL HYPERTENSION

Dialysis Methods May Affect Carotid Intima–Media Thickness in Chinese End-Stage Renal Disease Patients

A Cross-Sectional Study in a Greek Population

Lack of concordance between plasma markers of cardiovascular risk and intima-media thickness in patients with type 2 diabetes

Assessment of epicardial adipose tissue and carotid/femoral intima media thickness in insulin resistance

Why is cardiovascular risk stratification important in hypertensive patients?

Diagnostic Values of Epicardial Adipose Tissue Thickness with Right Common Carotid Artery Elasticity and Intima-Media Thickness for Middle-Aged and Elderly Patients with Coronary Heart Disease

Relationship between carotid intima-media thickness and metabolic markers in patients with essential hypertension

Retinal microvascular changes and target organ damage in untreated essential hypertensives

Determinants of Carotid Wall Echolucency in a Cohort of European High Cardiovascular Risk Subjects: A Cross-Sectional Analysis of IMPROVE Baseline Data

Intima-Media Thickness of Carotid Arteries and Endothelium-Dependent Vasodilation Function in Elderly Hypertensive Patients

Association between Endocan, PAI-1 and intima media thickness in patients with high diabetes risk